Merten Thomas, Dandachi-FitzGerald Brechje, Hall Vicki, Bodner Thomas, Giromini Luciano, Lehrner Johann, González-Ordi Héctor, Santamaría Pablo, Schmand Ben, Di Stefano Giuseppe
Department of Neurology, Vivantes Klinikum Im Friedrichshain, Berlin, Germany.
Department of Clinical Psychological Science, Maastricht University, Maastricht, The Netherlands.
Psychol Inj Law. 2022;15(2):116-127. doi: 10.1007/s12207-021-09436-8. Epub 2021 Nov 24.
In 2013, a special issue of the Spanish journal published a review on symptom and performance validity assessment in European countries (Merten et al. in , 24(3), 129-138, 2013). At that time, developments were judged to be in their infancy in many countries, with major publication activities stemming from only four countries: Spain, The Netherlands, Great Britain, and Germany. As an introduction to a special issue of , this is an updated report of developments during the last 10 years. In that period of time, research activities have reached a level where it is difficult to follow all developments; some validity measures were newly developed, others were adapted for European languages, and validity assessment has found a much stronger place in real-world evaluation contexts. Next to an update from the four nations mentioned above, reports are now given from Austria, Italy, and Switzerland, too.
2013年，西班牙一本期刊的特刊发表了一篇关于欧洲国家症状及表现效度评估的综述（默滕等人，发表于《[期刊名称]》，2013年第24卷第3期，第129 - 138页）。当时，许多国家的相关进展被认为尚处于起步阶段，主要的出版活动仅来自四个国家：西班牙、荷兰、英国和德国。作为《[期刊名称]》特刊的引言，这是过去十年发展情况的最新报告。在那段时间里，研究活动已达到难以全面追踪所有进展的程度；一些效度测量方法是新开发的，其他一些则针对欧洲语言进行了调整，并且效度评估在实际评估环境中占据了更为重要的地位。除了上述四个国家的最新情况外，现在还给出了奥地利、意大利和瑞士的报告。
